Effect of inhaled β2-agonist on exhaled nitric oxide in chronic obstructive pulmonary disease

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Amer, Mostafa ^a   Cowan, Jan ^a   Gray, Andrew ^a   Brockway, Ben ^a   Dummer, Jack ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; EXHALED NITRIC OXIDE; NITRIC OXIDE; UNCLASSIFIED DRUG; BRONCHODILATING AGENT;

ADULT; AGED; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXHALATION; EXPIRATORY FLOW; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MALE; MIDDLE AGED; SMOKING; SPIROMETRY; BREATH ANALYSIS; CLINICAL TRIAL; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADMINISTRATION, INHALATION; AGED; BREATH TESTS; BRONCHODILATOR AGENTS; EXHALATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84973299853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0157019     Document Type: Article

References (35)

1. Alving K, Malinovschi A. Basic aspects of exhaled nitric oxide. Exhaled biomarkers. European Respiratory Society Monographs: European Respiratory Society. 2010:1-31.
2. Berry MA, Shaw DE, Green RH, Brightling CE, Wardlaw AJ, Pavord ID. The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2005; 35(9):1175-9. doi: 10.1111/j.1365-2222.2005.02314.x PMID: 16164444.
3. Ricciardolo FL. Revisiting the role of exhaled nitric oxide in asthma. Curr Opin Pulm Med. 2014; 20(1):53-9. doi: 10.1097/MCP.0000000000000006 PMID: 24275926.
4. Smith A, Cowan J, Brassett K, Filsell S, Mclachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. American Journal of Respiratory & Critical Care Medicine. 2005; 172(4):453-9.
5. Silkoff PE, Wakita S, Chatkin J, Ansarin K, Gutierrez C, Caramori M, et al. Exhaled nitric oxide after beta2-agonist inhalation and spirometry in asthma. American journal of respiratory and critical care medicine. 1999; 159(3):940-4. doi: 10.1164/ajrccm.159.3.9805044 PMID: 10051277.
6. Cattoni I, Guarnieri G, Tosetto A, Mason P, Scarpa M, Saetta M, et al. Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction. Chest. 2013; 143(5):1269-76. doi: 10.1378/chest.12-1374 PMID: 23370456
7. Haccuria A, Michils A, Michiels S, Van Muylem A. Exhaled nitric oxide: a biomarker integrating both lung function and airway inflammation changes. Journal of Allergy & Clinical Immunology. 2014; 134(3):554-9. PubMed Central PMCID: PMC2014.
8. Hanania NA, Celli BR, Donohue JF, Martin UJ. Bronchodilator reversibility in COPD. Chest. 2011; 140(4):1055-63. doi: 10.1378/chest.10-2974 PMID: 21972384.
9. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine. 2000; 162(5):1773-7.
10. Chou K, Su K, Huang S, Hsiao Y, Tseng C, Su V, et al. Exhaled nitric oxide predicts eosinophilic airway inflammation in COPD. Lung. 2014; 192(4):499-504. doi: 10.1007/s00408-014-9591-8 PMID: 24816967
11. Dummer J, Epton M, Cowan J, Cook J, Condliffe R, Landhuis C, et al. Predicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxide. American Journal of Respiratory and Critical Care Medicine. 2009; 180(9):846-52. doi: 10.1164/rccm.200905-0685OC PMID: 19661244
12. Siva R, Green RH, Brightling CE, Shelley M, Hargadon B, McKenna S, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. The European respiratory journal. 2007; 29(5):906-13. doi: 10.1183/09031936.00146306 PMID: 17301099.
13. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. The European respiratory journal. 2005; 26(1):52-9. doi: 10.1183/09031936.04.00125304 PMID: 15994389.
14. Condorelli P, Shin H, Aledia A, Silkoff P, George S. A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model. Journal of Applied Physiology. 2007; 102(1):417-25. PMID: 16888048
15. Paredi P, Kharitonov S, Meah S, Barnes P, Usmani O. A novel approach to partition central and peripheral airway nitric oxide. Chest. 2014; 145(1):113-9. doi: 10.1378/chest.13-0843 PMID: 23989961
16. Barnes N. The properties of inhaled corticosteroids: similarities and differences. Primary Care Respiratory Journal. 2007; 16(3):149-54. PMID: 17530144
17. Doherty D, Belfer M, Brunton S, Fromer L, Morris C, Snader T. Chronic Obstructive Pulmonary Disease: consensus recommendations for early diagnosis and treatment. Journal of Family Practice. 2006; 55(11):S1-S8.
18. Jones P, Harding G, Berry P, Wiklund I, Chen W, Kline Leidy N. Development and first validation of the COPD assessment test. European Respiratory Journal. 2009; 34(3):648-54. doi: 10.1183/09031936.00102509 PMID: 19720809
19. American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American journal of respiratory and critical care medicine. 2005; 171(8):912-30. doi: 10.1164/rccm.200406-710ST PMID: 15817806.
20. Deykin A, Halpern O, Massaro AF, Drazen JM, Israel E. Expired nitric oxide after bronchoprovocation and repeated spirometry in patients with asthma. American journal of respiratory and critical care medicine. 1998; 157(3 Pt 1):769-75. doi: 10.1164/ajrccm.157.3.9707114 PMID: 9517589.
21. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. The European respiratory journal. 2005; 26(5):948-68. doi: 10.1183/09031936.05.00035205 PMID: 16264058.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. The European respiratory journal. 2005; 26(2):319-38. doi: 10.1183/09031936.05.00034805 PMID: 16055882.
23. Sears MR, Lotvall J. Past, present and future - beta2-adrenoceptor agonists in asthma management. Respir Med. 2005; 99(2):152-70. PMID: 15715182.
24. Silkoff P, McClean P, Slutsky A, Furlott H, Hoffstein E, Wakita S, et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. American Journal of Respiratory and Critical Care Medicine. 1997; 155(1):260-7. PMID: 9001322
25. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American journal of respiratory and critical care medicine. 2013; 187(4):347-65. doi: 10.1164/rccm.201204-0596PP PMID: 22878278.
26. Tsoukias N, George S. A two-compartment model of pulmonary nitric oxide exchange dynamics. Journal of Applied Physiology. 1998; 85(2):653-66. PMID: 9688744
27. Kharitonov SA, Sapienza MA, Barnes PJ, Chung KF. Prostaglandins E2 and F2alpha reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. American journal of respiratory and critical care medicine. 1998; 158(5 Pt 1):1374-8. doi: 10.1164/ajrccm.158.5.9707076 PMID: 9817681.
28. Zhao H, Li R, Lv Y, Dong H, Yao L, Wu Y, et al. Albuterol inhalation increases FeNO level in steroidnaive asthmatics but not COPD patients with reversibility. Clin Respir J. 2015. doi: 10.1111/crj.12340 PMID: 26077165.
29. Malerba M, Radaeli A, Olivini A, Damiani G, Ragnoli B, Montuschi P, et al. Exhaled nitric oxide as a biomarker in COPD and related comorbidities. Biomed Res Int. 2014; 2014:271918. doi: 10.1155/2014/271918 PMID: 24719850; PubMed Central PMCID: PMCPMC3955647.
30. Chorley BN, Li Y, Fang S, Park JA, Adler KB. (R)-albuterol elicits antiinflammatory effects in human airway epithelial cells via iNOS. Am J Respir Cell Mol Biol. 2006; 34(1):119-27. doi: 10.1165/rcmb.2005-0338OC PMID: 16195534; PubMed Central PMCID: PMC2644187.
31. de Gouw HW, Hendriks J, Woltman AM, Twiss IM, Sterk PJ. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. American journal of respiratory and critical care medicine. 1998; 158(1):315-9. doi: 10.1164/ajrccm.158.1.9703005 PMID: 9655746.
32. Lehtimaki L, Cristescu SM, Van Muylem A, Hogman M, Dinh-Xuan AT. How to assess alveolar nitric oxide: a quest of the grail? Chest. 2014; 146(6):e234-5. doi: 10.1378/chest.14-1189 PMID: 25451377.
33. Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015; 3(6):435-42. doi: 10.1016/S2213-2600(15)00106-X PMID: 25878028.
34. Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. American journal of respiratory and critical care medicine. 2011; 184(5):602-15. doi: 10.1164/rccm.9120-11ST PMID: 21885636.
35. Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology. 2009; 39(4):478-90. doi: 10.1111/j.1365-2222.2009.03226.x PMID: 19260871.